News | June 11, 2009

STERIS, Siemens to Develop Hybrid Surgical Suites

June 11, 2009 - Surgical support and integration technologies company STERIS Corp. and Siemens Medical Solutions USA Inc. said they are collaborating to offer optimized vascular, cardiovascular and neurosurgical hybrid surgical suites. The collaboration was announced today at the Society of Vascular Surgeons annual meeting in Denver, Colo. Through this collaboration, Siemens will provide advanced information and interventional technologies, while STERIS will supply what it calls custom-designed HD 360° Suites, featuring LED surgical lighting and visualization systems as well as OR integration and equipment management solutions. STERIS will also provide expert room design and project management services using the company’s three-dimensional Room Builder software. The hybrid suites that result from STERIS and Siemens joint efforts will enable surgical and diagnostic teams to carry out a vast range of image-guided cardiovascular, vascular, and neurosurgical interventional procedures as well as open surgeries. “Working together, we can help facilities meet growing procedural demands and provide the technology that will integrate capabilities for new interventional procedures, minimally invasive surgeries and open procedures, all in the same space,” said Bill O’Riordan, vice president and general manager, STERIS Surgical Solutions. “This collaboration will also able to help healthcare providers embrace future surgical innovation with ease.” “As the needs of today’s surgical suite expand to accommodate both minimally invasive techniques and complex open surgical procedures within the same environment, state-of-the-art image-guidance technologies, such as our Artis zee family, including the first-to-market Artis zeego, are being incorporated into surgical workflow to improve clinical, operational, and financial efficiency,” said Claus Grill, vice president, cardiac, interventional/neuro, and X-ray systems, Siemens Healthcare. The Siemens-STERIS collaboration will deliver hybrid operating room solutions that enable healthcare facilities to improve workflow and streamline room planning and installation, the companies said. For more information:,

Related Content

SherpaPak Cardiac Transport System Cleared for Pediatric and Small Donor Hearts
Technology | Cardiovascular Surgery | February 01, 2019
Paragonix Technologies Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) for a design...
Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Overlay Init